TY  - GEN
AU  - Wang,Zhen
AU  - Huang,Cheng
AU  - Yang,Jin-Ji
AU  - Song,Yong
AU  - Cheng,Ying
AU  - Chen,Gong-Yan
AU  - Yan,Hong-Hong
AU  - Ben,Xiao-Song
AU  - Wang,Bin-Chao
AU  - Xu,Chong-Rui
AU  - Jiang,Ben-Yuan
AU  - Zhou,Qing
AU  - Chen,Hua-Jun
AU  - Wu,Yi-Long
TI  - A randomised phase II clinical trial of nab-paclitaxel and carboplatin compared with gemcitabine and carboplatin as first-line therapy in advanced squamous cell lung carcinoma (C-TONG1002)
SN  - 1879-0852
PY  - 2020///0521
KW  - Adult
KW  - Aged
KW  - Albumins
KW  - administration & dosage
KW  - Antineoplastic Combined Chemotherapy Protocols
KW  - therapeutic use
KW  - Carboplatin
KW  - Carcinoma, Non-Small-Cell Lung
KW  - drug therapy
KW  - Carcinoma, Squamous Cell
KW  - Deoxycytidine
KW  - Female
KW  - Follow-Up Studies
KW  - Humans
KW  - Lung Neoplasms
KW  - Male
KW  - Middle Aged
KW  - Paclitaxel
KW  - Prognosis
KW  - Quality of Life
KW  - Survival Rate
KW  - Gemcitabine
N1  - Publication Type: Clinical Trial, Phase II; Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
UR  - https://doi.org/10.1016/j.ejca.2019.01.007
ER  -